AKZOY:OTC-Akzo Nobel N.V (USD)

COMMON STOCK | Specialty Chemicals | OTC

Last Closing Price

USD 31.11

Change

0.00 (0.00)%

Market Cap

USD 18.40B

Volume

0.03M

Average Target Price

N/A
Average Analyst Rating

Verdict

Fundamental Analysis

Verdict

About

Akzo Nobel N.V. operates as a paints and coatings company worldwide. It offers decorative paints, including paints, lacquers, and varnishes; a range of mixing machines and color concepts for the building and renovation industry; and specialty coatings for metal, wood, and other building materials. The company also provides performance coatings to protect and enhance ships, cars, aircraft, yachts, architectural components, consumer goods, and oil and gas facilities. It offers its products primarily under Dulux, International, Sikkens, and Interpon brands. The company was formerly known as Akzo NV and changed its name to Akzo Nobel N.V. in 1994. Akzo Nobel N.V. was founded in 1646 and is headquartered in Amsterdam, the Netherlands.

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2020-09-28 )

Largest Industry Peers for Specialty Chemicals

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
GVDNY Givaudan SA

+0.27 (+0.32%)

USD39.56B 49.77 34.02
GVDBF Givaudan SA

+166.96 (+3.99%)

USD39.36B 50.71 34.02
SXYAY Sika AG

-0.04 (-0.17%)

USD34.56B 49.20 28.41
SKFOF Sika AG

N/A

USD33.85B 48.89 28.41
NPCPF Nippon Paint Holdings Co., Ltd

N/A

USD32.74B 74.09 0.33
KDSKF Koninklijke DSM N.V

N/A

USD27.21B 38.10 24.90
RDSMY Koninklijke DSM N.V

+0.30 (+0.77%)

USD27.02B 38.03 24.90
EMSHF EMS-CHEMIE HOLDING AG

N/A

USD21.05B 42.50 39.16
AKZOF Akzo Nobel N.V

N/A

USD18.84B 38.38 16.78
SYIEY Symrise AG

-0.03 (-0.09%)

USD18.76B 50.81 27.56

ETFs Containing AKZOY

Symbol Name Weight Mer Price(Change) Market Cap

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Specialty Chemicals)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -8.63% N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return -8.63% N/A N/A N/A N/A
Trailing 12 Months  
Capital Gain 4.99% N/A N/A N/A N/A
Dividend Return 0.51% N/A N/A N/A N/A
Total Return 5.51% N/A N/A N/A N/A
Trailing 5 Years  
Capital Gain 44.50% N/A N/A N/A N/A
Dividend Return 39.96% N/A N/A N/A N/A
Total Return 84.46% N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 8.83% N/A N/A N/A N/A
Dividend Return 7.36% N/A N/A N/A N/A
Total Return 16.19% N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 19.39% N/A N/A N/A N/A
Risk Adjusted Return 83.49% N/A N/A N/A N/A
Market Capitalization 18.40B N/A N/A N/A N/A
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Specialty Chemicals)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 35.66 N/A N/A N/A N/A
Price/Book Ratio 2.65 N/A N/A N/A N/A
Price / Cash Flow Ratio 557.72 N/A N/A N/A N/A
EV/EBITDA 16.35 N/A N/A N/A N/A
Management Effectiveness  
Return on Equity 7.68% N/A N/A N/A N/A
Return on Invested Capital 5.45% N/A N/A N/A N/A
Return on Assets 3.76% N/A N/A N/A N/A
Debt to Equity Ratio 28.03% N/A N/A N/A N/A
Technical Ratios  
Short Ratio 1.23 N/A N/A N/A N/A
Short Percent N/A N/A N/A N/A N/A
Beta 1.05 N/A N/A N/A N/A
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:

There is nothing we particularly dislike